Cover Image

Corrigendum: Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape

Saved in:

Bibliographic Details
Main Authors:	Sisi Xie (Author), Shu Li (Author), Jing Tian (Author), Fen Li (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
by: Sisi Xie, et al.
Published: (2020)

Conflict between efficacy and economy in rheumatoid arthritis treatment: Iguratimod is found at a compromise
by: Masao Tanaka
Published: (2021)

Effectiveness and safety of iguratimod treatment in patients with active rheumatoid arthritis in Chinese: A nationwide, prospective real-world study
by: Rong Mu, et al.
Published: (2021)

Regulatory Effect of Iguratimod on the Balance of Th Subsets and Inhibition of Inflammatory Cytokines in Patients with Rheumatoid Arthritis
by: Yunzhi Xu, et al.
Published: (2015)

Effectiveness and Safety of Iguratimod Monotherapy or Combined With Methotrexate in Treating Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
by: Dan Ouyang, et al.
Published: (2022)

The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
by: Shahin Shams, et al.
Published: (2021)

The Effect and Safety of Iguratimod Combined With Methotrexate on Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Based on a Randomized Controlled Trial
by: Liuting Zeng, et al.
Published: (2022)

A systematic review and meta-analysis of the efficacy and safety of iguratimod in the treatment of inflammatory arthritis and degenerative arthritis
by: Zhiyong Long, et al.
Published: (2024)

Multiomics landscape of synovial fibroblasts in rheumatoid arthritis
by: Haruka Tsuchiya, et al.
Published: (2021)

Corrigendum: An integrative pharmacology model for decoding the underlying Therapeutic Mechanisms of Ermiao Powder for Rheumatoid arthritis
by: Jie Wu, et al.
Published: (2023)

New Developments in the Pathogenesis of Rheumatoid Arthritis
Published: (2017)

New classification criteria for rheumatoid arthritis
by: R. Caproali, et al.
Published: (2011)

Safety, Tolerability, and Pharmacokinetics of Ibuprofenamine Hydrochloride Spray (NSAIDs), a New Drug for Rheumatoid Arthritis and Osteoarthritis, in Healthy Chinese Subjects
by: Xie P, et al.
Published: (2021)

Is yoga a suitable treatment for rheumatoid arthritis: current opinion
by: Telles S, et al.
Published: (2012)

Individualized Drug Repositioning For Rheumatoid Arthritis Using Weighted Kolmogorov–Smirnov Algorithm
by: Hu RY, et al.
Published: (2019)

Iguratimod Attenuates Macrophage Polarization and Antibody-Mediated Rejection After Renal Transplant by Regulating KLF4
by: Zhou Hang, et al.
Published: (2022)

ADALIMUMAB: NEW OPPORTUNITIES OF RHEUMATOID ARTHRITIS TREATMENT
by: E.I. Alexeeva, et al.
Published: (2009)

ADALIMUMAB: NEW OPPORTUNITIES OF RHEUMATOID ARTHRITIS TREATMENT
by: E.I. Alexeeva, et al.
Published: (2009)

Effectiveness and Safety of Iguratimod in Treating Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis
by: Jincheng Pu, et al.
Published: (2021)

iTRAQ and PRM-Based Proteomic Analysis Provides New Insights into Mechanisms of Response to Triple Therapy in Patients with Rheumatoid Arthritis
by: Chen J, et al.
Published: (2021)

Drug-related problems in patients with rheumatoid arthritis
by: Ma SN, et al.
Published: (2019)

Therapeutic effect of various ginsenosides on rheumatoid arthritis
by: Meng Zhang, et al.
Published: (2021)

Bioactive Molecules against Rheumatoid Arthritis by Suppressing Pyroptosis
by: Qian Zhou, et al.
Published: (2023)

Pharmacological Aspects of Natural Quercetin in Rheumatoid Arthritis
by: Tang M, et al.
Published: (2022)

Drug repurposing for rheumatoid arthritis: Identification of new drug candidates via bioinformatics and text mining analysis
by: Ulku Unal, et al.
Published: (2022)

Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape
by: Neal M. Davies (Ed.)
Published: (2018)

Rheumatoid arthritis
by: Yoshiya Tanaka
Published: (2020)

Repurposing of Pirfenidone (Anti-Pulmonary Fibrosis Drug) for Treatment of Rheumatoid Arthritis
by: Donghao Gan, et al.
Published: (2021)

Rheumatoid Arthritis
Published: (2022)

Kunxian Capsule for Rheumatoid Arthritis: Inhibition of Inflammatory Network and Reducing Adverse Reactions Through Drug Matching
by: Yujun Tang, et al.
Published: (2020)

Immunomodulatory nano-preparations for rheumatoid arthritis
by: Chenglong Li, et al.
Published: (2023)

Carbon Nanotubes-Potent Carriers for Targeted Drug Delivery in Rheumatoid Arthritis
by: Camilla Kofoed Andersen, et al.
Published: (2021)

Artrite reumatoide: uma visão atual Rheumatoid arthritis: a current view
by: Isabela Goeldner, et al.
Published: (2011)

Rheumatoid Arthritis Treatment
Published: (2012)

Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials
by: Liuting Zeng, et al.
Published: (2023)

Naringenin nanocrystals for improving anti-rheumatoid arthritis activity
by: Guangshuai Zhang, et al.
Published: (2021)

Skin in rheumatoid arthritis and seronegative arthritis
by: Pragathi Sankineni, et al.
Published: (2019)

Nanomaterials Manipulate Macrophages for Rheumatoid Arthritis Treatment
by: Shuang Li, et al.
Published: (2021)

Recent advances in nano-targeting drug delivery systems for rheumatoid arthritis treatment
by: Hanmei Li, et al.
Published: (2023)

New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib
by: Kawalec P, et al.
Published: (2019)